The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Ontada/McKesson
Predictors of biomarker testing among patients (pts) with metastatic non–small cell lung cancer (mNSCLC).
 
Nicholas J. Robert
Employment - McKesson
Leadership - McKesson
Stock and Other Ownership Interests - McKesson; Moderna Therapeutics; Oncolytics (I)
Honoraria - Bristol-Myers Squibb; Roche
Consulting or Advisory Role - Advi; Boehringer Ingelheim; Bristol-Myers Squibb; New Century Health
 
Liwei Chen
No Relationships to Disclose
 
Janet L. Espirito
No Relationships to Disclose
 
Mandar Karhade
Employment - Ontada/McKesson
Stock and Other Ownership Interests - McKesson
Research Funding - McKesson
 
Makenzi Colleen Evangelist
Consulting or Advisory Role - AstraZeneca; Mirati Therapeutics; Regeneron; Takeda
 
Marcus A. Neubauer
Leadership - McKesson
Travel, Accommodations, Expenses - McKesson
 
Susie A. Bullock
Employment - McKesson
Stock and Other Ownership Interests - McKesson
 
Jennifer M. Walberg
Employment - McKesson
Stock and Other Ownership Interests - McKesson
 
Robert L. Coleman
Employment - US Oncology
Leadership - Onxeo
Stock and Other Ownership Interests - McKesson
Consulting or Advisory Role - Abbvie; Abbvie/Stemcentrx; Agenus; Alkermes; AstraZeneca/MedImmune; Clovis Oncology; Genentech/Roche; Genmab; Gradalis; Immunogen; Merck; Merck; Novocure; Oncolytics; OncoMed; OncXerna Therapeutics; Regeneron; Sotio; Tesaro
Research Funding - Abbott/AbbVie; Amgen (Inst); Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Immunogen (Inst); Johnson & Johnson; Lilly (Inst); Merck; Mirati Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst); Roche/Genentech
Travel, Accommodations, Expenses - Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Clovis Oncology; GOG Foundation; Merck; Research to Practice; Roche/Genentech; Sotio; Vaniam Group